|1.||Sparber, Sheldon B: 2 articles (11/2004 - 10/2002)|
|2.||Schrott, Lisa M: 2 articles (11/2004 - 10/2002)|
|3.||Wang, Hongge: 1 article (01/2003)|
|4.||Kang, Jiesheng: 1 article (01/2003)|
|5.||Chen, Xiao Liang: 1 article (01/2003)|
|6.||Rampe, David: 1 article (01/2003)|
|7.||Zhang, Xuewei: 1 article (10/2002)|
|8.||Baumgart, Mary Irene: 1 article (10/2002)|
|1.||Opioid-Related Disorders (Opiate Addiction)
01/01/2003 - "We conclude that the proarrhythmic effects of l-alpha-acetylmethadol are due to specific blockade of the HERG cardiac K(+) channel and that its active metabolite noracetylmethadol may provide a safer alternative in the treatment of opiate addiction."
09/01/1995 - "This study evaluated levo-alpha-noracetylmethadol (NorLAAM), the first N-demethylated metabolite of levo-alpha-acetylmethadol (LAAM), a long-acting morphine-like (mu) agonist, approved in 1993 to treat opiate dependence. "
11/01/2004 - "We have established procedures to reliably induce opiate dependence in the chick embryo via in ovo injection, early in embryonic development, of the long-acting and potent opiate N-desmethyl-l-alpha-noracetylmethadol (NLAAM). "
10/01/2002 - "In ovo administration of the long-acting opiate N-desmethyl-l-alpha-noracetylmethadol (NLAAM) induces opiate dependence in the chick embryo. "
08/01/1997 - "The discriminative stimulus effects of l-alpha-acetylmethadol (LAAM), l-alpha-acetylnormethadol (nor-LAAM), l-alpha-acetyldinormethadol (dinor-LAAM), buprenorphine and methadone were investigated in morphine-treated (3.2 mg/kg/day) rhesus monkeys (n = 3-6) discriminating between saline and naltrexone (0.01 mg/kg) and responding under a fixed ratio (FR) schedule of stimulus-shock termination. "
|1.||Methadyl Acetate (LAAM)
|2.||Morphine (MS Contin)